C. Chin

发表

Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1

O. Vafa, T. Raju, Randall J Brezski, 2012, Journal of molecular recognition : JMR.

TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway

R. Verona, B. Tomkowicz, S. Santulli-Marotto, 2015, PloS one.

The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor.

J. Murphy, D. Kendall, C. Chin, 1999, The Journal of pharmacology and experimental therapeutics.

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates

T. Cash-Mason, M. Hunter, J. Chavez, 2017, Nature Medicine.

Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.

I. Wang, J. Berger, P. Lu, 2009, European Journal of Pharmacology.

Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo.

Margaret S. Wu, I. Wang, J. Berger, 2009, European journal of pharmacology.

Involvement of the Carboxyl Terminus of the Third Intracellular Loop of the Cannabinoid CB1 Receptor in Constitutive Activation of Gs

D. Kendall, C. Chin, V. Abadji, 1999, Journal of neurochemistry.

Therapeutic Antibodies in Clinical Use and Leading Clinical Candidates

P. Lu, Ningyan Zhang, Z. An, 2009 .

Transmembrane homodimerization of receptor‐like protein tyrosine phosphatases

D. Engelman, J. Sachs, C. Chin, 2005, FEBS letters.

Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail.

G. von Heijne, H. Andersson, D. Kendall, 2003, Molecular pharmacology.

Ligand Binding and Modulation of Cyclic AMP Levels Depend on the Chemical Nature of Residue 192 of the Human Cannabinoid Receptor 1

D. Kendall, C. Chin, V. Abadji, 1998, Journal of neurochemistry.

Abstract 6706: Systemic administration of STING agonist antibody-drug conjugates elicit potent anti-tumor immune responses with minimal induction of circulating cytokines

Jeremy R. Duvall, M. Protopopova, S. Collins, 2020 .

Rapid topology mapping of Escherichia coli inner-membrane proteins by prediction and PhoA/GFP fusion analysis

Johan Nilsson, Gunnar von Heijne, David Drew, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Abstract 907: XMT-1660, a B7-H4-targeted Dolasynthen antibody-drug conjugate for the treatment of breast cancer

Steven P. Bradley, S. Collins, Phonphimon Wongthida, 2021, Experimental and Molecular Therapeutics.

Abstract 2687: Dolasynthen–a novel, homogeneous Auristatin F hydroxypropyl amide antibody-drug conjugate platform

S. Collins, M. Damelin, Liuliang Qin, 2019, Experimental and Molecular Therapeutics.

Membrane protein folding: beyond the two stage model

Alessandro Senes, Ursula Lehnert, Yana K Reshetnyak, 2003, FEBS letters.

Membrane proteins: shaping up.

G. von Heijne, J. de Gier, C. Chin, 2002, Trends in biochemical sciences.

Charge pair interactions in a model transmembrane helix in the ER membrane.

G. von Heijne, C. Chin, 2000, Journal of molecular biology.

Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.

I. Wang, J. Berger, P. Lu, 2009, European journal of pharmacology.

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer

Jeremy R. Duvall, S. Collins, Phonphimon Wongthida, 2023, Molecular cancer therapeutics.